牙周病和糖尿病:一个系统的审查
1Department of Oral and Maxillofacial Surgery and Diagnostic Science, Taif University, Taif, Saudi Arabia.
Journal of pharmacy & bioallied sciences
|September 1, 2023
概括
患有糖尿病的人患牙周炎的风险增加了86%. 这一系统性审查强调了糖尿病和牙周炎进展之间的重要联系,强调了需要进一步研究的必要性.
科学领域:
- 牙周病学 牙周病学
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 牙周炎和糖尿病之间的关联是公认的,但现有的文献提出了相互矛盾的发现.
- 控制不良的糖尿病可疑会影响牙周炎的发展和进展.
研究的目的:
- 系统地审查和定义控制不良的糖尿病与牙周炎的发展或进展之间的联系.
主要方法:
- 进行了对纵向 (前性) 研究的系统审查,搜索了PubMed,Scopus,Embase和谷歌学者.
- 包括的研究评估了牙周炎和糖尿病,使用至少两个牙周健康参数.
- 使用元分析来确定与糖尿病相关的高血糖症对牙周炎的影响,使用子组分析和元回归来探索异质性.
主要成果:
- 该审查包括13项研究,涉及49262名参与者,其中3197人患有糖尿病.
- 对调整后估计的元分析显示,糖尿病增加了86%的牙周炎发展或发展为牙周炎的可能性 (RR 1.86;95% CI 1.3-2.8).
结论:
- 这项研究提供了证据表明,糖尿病患者面临患有牙周炎的风险较高.
- 建议在未来进行前性的纵向调查,以解决本次审查中发现的方法限制.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Pathophysiology of Diabetes
986
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
986
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Oral Hypoglycemic Agents: Biguanides and Glitazones
230
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
230
Diabetes: Symptoms, Diagnosis, and Complications
588
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
588
Diabetes: Management and Pharmacotherapy
310
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
310


